Cortical hypoperfusion in the B6.PS2APP mouse model for Alzheimer's disease: Comprehensive phenotyping of vascular and tissular parameters by MRI

Magnetic Resonance in Medicine

Volumn 62, Issue 1, 2009, Pages 35-45

  Weidensteiner, Claudia ^a,b   Metzger, Friedrich ^a   Bruns, Andreas ^a   Bohrmann, Bernd ^a   Kuennecke, Basil ^a   Von Kienlin, Markus ^a  

^a F HOFFMANN LA ROCHE LTD   (Switzerland)

^b UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Alzheimer's disease; Cerebral blood volume; Mouse model; Perfusion; Relaxation times; Vessel density and size

Indexed keywords

BLOOD; DEPOSITION; HEMODYNAMICS; MAMMALS; RELAXATION TIME;

ALZHEIMER'S DISEASE; CEREBRAL BLOOD VOLUME; MOUSE MODELS; PERFUSION; RELAXATION TIMES; VESSEL DENSITY AND SIZE;

NEURODEGENERATIVE DISEASES;

ALZHEIMER DISEASE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD VOLUME; BRAIN PERFUSION; CONTROLLED STUDY; HISTOPATHOLOGY; IMAGE QUALITY; IMMUNOHISTOCHEMISTRY; MOUSE; NONHUMAN; NUCLEAR MAGNETIC RESONANCE IMAGING; PHENOTYPE; SUBICULUM; VASCULARIZATION;

EID: 67650097328     PISSN: 07403194     EISSN: 15222594     Source Type: Journal    
DOI: 10.1002/mrm.21985     Document Type: Article

References (43)

1. Grammas P. A damaged microcirculation contributes to neuronal cell death in Alzheimer's disease. Neurobiol Aging 2000;21:199-205.
2. Shi J, Perry G, Smith MA, Friedland RP. Vascular abnormalities: the insidious pathogenesis of Alzheimer's disease. Neurobiol Aging 2000;21:357-361.
3. Johnson KA, Albert MS. Perfusion abnormalities in prodromal AD. Neurobiol Aging 2000;21:289-292.
4. de la Torre JC. Is Alzheimer's disease a neurodegenerative or a vascular disorder? Data, dogma, and dialectics. Lancet Neurol 2004;3:184-190.
5. Iadecola C. Neurovascular regulation in normal brain and in Alzheimer's disease. Nat Rev Neurosci 2004;5:347-360.
6. Higgins GA, Jacobsen H. Transgenic mouse models of Alzheimer's disease: phenotype and application. Behav Pharmacol 2003;14:419-438.
7. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein. Neurobiol Dis 2002;9:61-68.
8. Beckmann N, Schuler A, Mueggler T, Meyer EP, Wiederhold KH, Staufenbiel M, Krucker T. Age-dependent cerebrovascular abnormalities and blood flow disturbances in APP23 mice modeling Alzheimer's disease. J Neurosci 2003;23:8453-8459.
9. Mueggler T, Sturchler-Pierrat C, Baumann D, Rausch M, Staufenbiel M, Rudin M. Compromised hemodynamic response in amyloid precursor protein transgenic mice. J Neurosci 2002;22:7218-7224.
10. von Kienlin M, Kuennecke B, Metzger F, Steiner G, Richards JG, Ozmen L, Jacobsen H, Loetscher H. Altered metabolic profile in the frontal cortex of PS2APP transgenic mice, monitored throughout their life span. Neurobiol Dis 2005;18:32-39.
11. Alsop DC, Detre JA, Grossman M. Assessment of cerebral blood flow in Alzheimer's disease by spin-labeled magnetic resonance imaging. Ann Neurol 2000;47:93-100.
12. Johnson NA, Jahng GH, Weiner MW, Miller BL, Chui HC, Jagust WJ, Gorno-Tempini ML, Schuff N. Pattern of cerebral hypoperfusion in Alzheimer disease and mild cognitive impairment measured with arterial spin-labeling MR imaging: initial experience. Radiology 2005;234:851-859.
13. Duara R, Grady C, Haxby J, Schlageter N, Berg G, Rapoport SI. Positron emission tomography in Alzheimer's disease. Neurology 1986;36:879-887.
14. Johnson KA, Kijewski MF, Becker JA, Garada B, Satlin A, Holman BL. Quantitative brain SPECT in Alzheimer's disease and normal aging. J Nucl Med 1993;34:2044-2048.
15. Harris GJ, Lewis RF, Satlin A, English CD, Scott TM, Yurgelun-Todd DA, Renshaw PF. Dynamic susceptibility contrast MR imaging of regional cerebral blood volume in Alzheimer disease: a promising alternative to nuclear medicine. AJNR Am J Neuroradiol 1998;19:1727-1732.
16. Wu EX, Tang H, Asai T, Yan SD. Regional cerebral blood volume reduction in transgenic mutant APP (V717F, K670N/M671L) mice. Neurosci Lett 2004;365:223-227.
17. Wu EX, Tang H, Jensen JH. High-resolution MR imaging of mouse brain microvasculature using the relaxation rate shift index Q. NMR Biomed 2004;17:507-512.
18. Jensen JH, Chandra R. MR imaging of microvasculature. Magn Reson Med 2000;44:224-230.
19. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M. In vivo assessment of tumoral angiogenesis. Magn Reson Med 2004;51:533-541.
20. Troprès I, Grimault S, Vaeth A, Grillon E, Julien C, Payen JF, Lamalle L, Decorps M. Vessel size imaging. Magn Reson Med 2001;45:397-408.
21. Dennie J, Mandeville JB, Boxerman JL, Packard SD, Rosen BR, Weisskoff RM. NMR imaging of changes in vascular morphology due to tumor angiogenesis. Magn Reson Med 1998;40:793-799.
22. Helpern JA, Lee SP, Falangola MF, Dyakin VV, Bogart A, Ardekani B, Duff K, Branch C, Wisniewski T, de Leon MJ, Wolf O, O'Shea J, Nixon RA. MRI assessment of neuropathology in a transgenic mouse model of Alzheimer's disease. Magn Reson Med 2004;51:794-798.
23. 1H magnetic resonance spectroscopy study. Neurosci Lett 2004;362:167-170.
24. 2 time in hippocampus of human patients marks the presence and severity of Alzheimer's disease. Neurosci Lett 1992;134:187-190.
25. Benveniste H, Einstein G, Kim KR, Hulette C, Johnson GA. Detection of neuritic plaques in Alzheimer's disease by magnetic resonance microscopy. Proc Natl Acad Sci USA 1999;96:14079-14084.
26. Falangola MF, Lee SP, Nixon RA, Duff K, Helpern JA. Histological co-localization of iron in Abeta plaques of PS/APP transgenic mice. Neurochem Res 2005;30:201-205.
27. El Tannir El Tayara N, Delatour B, Le Cudennec C, Guegan M, Volk A, Dhenain M. Age-related evolution of amyloid burden, iron load, and MR relaxation times in a transgenic mouse model of Alzheimer's disease. Neurobiol Dis 2006;22:199-208.
28. Richards JG, Higgins GA, Ouagazzal AM, Ozmen L, Kew JN, Bohrmann B, Malherbe P, Brockhaus M, Loetscher H, Czech C, Huber G, Bluethmann H, Jacobsen H, Kemp JA. PS2APP transgenic mice, coexpressing hPS2mut and hAPPswe, show age-related cognitive deficits associated with discrete brain amyloid deposition and inflammation. J Neurosci 2003;23:8989-9003.
29. Williams DS, Detre JA, Leigh JS, Koretsky AP. Magnetic resonance imaging of perfusion using spin inversion of arterial water. Proc Natl Acad Sci USA 1992;89:212-216.
30. Alsop DC, Detre JA. Reduced transit-time sensitivity in noninvasive magnetic resonance imaging of human cerebral blood flow. J Cereb Blood Flow Metab 1996;16:1236-1249.
31. Haase A, Frahm J, Matthaei D, Hänicke W, Merboldt KD. FLASH imaging. Rapid NMR imaging using low flip-angle pulses. J Magn Reson 1986;67:258-266.
32. 1 mapping on a whole-body scanner. Magn Reson Med 1999;42:206-209.
33. Paxinos G, Franklin KBJ. The mouse brain in stereotactic coordinates. San Diego: Academic Press; 2001.
34. Rau PR, Sellner J, Heiland S, Plaschke K, Schellinger PD, Meyding-Lamadé UK, Lamadé WR. Apparent diffusion coefficient in the aging mouse brain: a magnetic resonance imaging study. Life Sci 2006;78:1175-1180.
35. Kouznetsova E, Klingner M, Sorger D, Sabri O, Grossmann U, Steinbach J, Scheunemann M, Schliebs R. Developmental and amyloid plaque-related changes in cerebral cortical capillaries in transgenic Tg2576 Alzheimer mice. Int J Dev Neurosci 2006;24:187-193.
36. Niwa K, Kazama K, Younkin SG, Carlson GA, Iadecola C. Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein. Am J Physiol Heart Circ Physiol 2002;283:H315-H323.
37. van Zijl PC, Eleff SM, Ulatowski JA, Oja JM, Ulug AM, Traystman RJ, Kauppinen RA. Quantitative assessment of blood flow, blood volume and blood oxygenation effects in functional magnetic resonance imaging. Nat Med 1998;4:159-167.
38. Sirs JA. The flow of human blood through capillary tubes. J Physiol 1991;442:569-583.
39. 2 changes in mouse models of Alzheimer's disease. NMR Biomed 2007;20:343-351.
40. Vanhoutte G, Dewachter I, Borghgraef P, Van Leuven F, Van der Linden A. Noninvasive in vivo MRI detection of neuritic plaques associated with iron in APP[V717I] transgenic mice, a model for Alzheimer's disease. Magn Reson Med 2005;53:607-613.
41. Faber C, Zahneisen B, Tippmann F, Schroeder A, Fahrenholz F. Gradient-echo and CRAZED imaging for minute detection of Alzheimer plaques in an APPV717I x ADAM10-dn mouse model. Magn Reson Med 2007;57:696-703.
42. 2: a theoretical and experimental approach. J Cereb Blood Flow Metab 2000;20:316-326.
43. O'Brien JT, Eagger S, Syed GM, Sahakian BJ, Levy R. A study of regional cerebral blood flow and cognitive performance in Alzheimer's disease. J Neurol Neurosurg Psychiatry 1992;55:1182-1187.